Teva Pharmaceutical Industries, Celebrates Transfer to New York Stock Exchange from NASDAQ - YouTube
Shlomo Yanai, incoming president and CEO (L), and Israel Makov, outgoing president and CEO of Teva Pharmaceutical Industries, Ltd. take part in the opening bell ceremonies at the NASDAQ in New York
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva Opens First Retail Store
TEVA Beats on Q1 Earnings and Sales, Keeps View, Stock Down
SweepCast on Twitter: "$TEVA $NASDAQ Several Bullish Call π Sweeps alerted today, with the largest for π€ $325K π€ worth of premium on https://t.co/lV6J6ljJGS #optionstrading #stocks #teva (Start your trial today!!) https://t.co/6bTXzZ9Zzz" /
Teva to pay up to $4.2 billion in U.S. to settle opioid claims | Nasdaq
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part
Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses Stake
San Diego Biotech Founder Charged with Insider Trading in $3.5 Billion Sale - Times of San Diego
Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product
From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part
Teva Pharmaceutical Industries Limited (TEVA) Stock 10 Year History